Title |
Monoamine oxidase inhibitors (MAOIs) for fibromyalgia syndrome
|
---|---|
Published in |
Cochrane database of systematic reviews, April 2012
|
DOI | 10.1002/14651858.cd009807 |
Pubmed ID | |
Authors |
Sera Tort, Gerard Urrútia, María Betina Nishishinya, Brian Walitt |
Abstract |
Fibromyalgia (FM) syndrome is a chronic condition of unknown aetiology characterised by musculoskeletal pain that often co-exists with sleep disturbance, cognitive dysfunction and fatigue. Patients often report high disability levels and poor quality of life. Since there is no specific treatment that alters the pathogenesis of FM, drug therapy focuses on pain reduction and improvement of other bothersome symptoms. |
X Demographics
The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 3 | 50% |
United Kingdom | 2 | 33% |
Switzerland | 1 | 17% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 6 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 156 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | <1% |
Spain | 1 | <1% |
Australia | 1 | <1% |
Unknown | 153 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 29 | 19% |
Student > Doctoral Student | 17 | 11% |
Researcher | 14 | 9% |
Student > Bachelor | 14 | 9% |
Student > Ph. D. Student | 13 | 8% |
Other | 28 | 18% |
Unknown | 41 | 26% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 52 | 33% |
Nursing and Health Professions | 17 | 11% |
Psychology | 14 | 9% |
Neuroscience | 6 | 4% |
Social Sciences | 5 | 3% |
Other | 20 | 13% |
Unknown | 42 | 27% |
Attention Score in Context
This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 July 2019.
All research outputs
#5,284,242
of 25,806,080 outputs
Outputs from Cochrane database of systematic reviews
#7,486
of 13,140 outputs
Outputs of similar age
#33,022
of 175,054 outputs
Outputs of similar age from Cochrane database of systematic reviews
#102
of 185 outputs
Altmetric has tracked 25,806,080 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,140 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.9. This one is in the 42nd percentile – i.e., 42% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 175,054 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 185 others from the same source and published within six weeks on either side of this one. This one is in the 44th percentile – i.e., 44% of its contemporaries scored the same or lower than it.